ABSTRACT
Purpose
To systematically evaluate the effect of formulation- and administration-related variables on nasal spray deposition using a nasal cast.
Methods
Deposition pattern was assessed by uniformly coating a transparent nose model with Sar-Gel®, which changes from white to purple on contact with water. Sprays were subsequently discharged into the cast, which was then digitally photographed. Images were quantified using Adobe® Photoshop. The effects of formulation viscosity (which influences droplet size), simulated administration techniques (head orientation, spray administration angle, spray nozzle insertion depth), spray pump design and metering volume on nasal deposition pattern were investigated.
Results
There was a significant decrease in the deposition area associated with sprays of increasing viscosity. This appeared to be mediated by an increase in droplet size and a narrowing of the spray plume. Administration techniques and nasal spray pump design also had a significant effect on the deposition pattern.
Conclusions
This simple color-based method provides quantitative estimates of the effects that different formulation and administration variables may have on the nasal deposition area, and provides a rational basis on which manufacturers of nasal sprays can base their patient instructions or post approval changes when it is impractical to optimize these using a clinical study.
Similar content being viewed by others
REFERENCES
Arora P, Sharma S, Garg S. Permeability issues in nasal drug delivery. Drug Discov Today. 2002;7(18):967–75.
Suman JD, Laube BL, Dalby R. Comparison of nasal deposition and clearance of aerosol generated by nebulizer and an aqueous spray pump. Pharm Res. 1999;16(10):1648–52.
Newman SP, Steed KP, Hardy JG, Wilding IR, Hooper G, Sparrow RA. The distribution of an intranasal insulin formulation in healthy volunteers: effect of different administration techniques. J Pharm Pharmacol. 1994;46:657–60.
Vidgren MT, Kublik H. Nasal delivery systems and their effect on deposition and absorption. Adv Drug Deliv Rev. 1998;29:157–77.
Food Drug Administration. U.S. FDA draft guidance for industry: bioavailability and bioequivalence studies for nasal aerosols and nasal sprays for local action. Rockville: US Food and Drug Administration; 2003.
Harris AS, Svensson E, Wagner ZG, Lethagen S, Nilsson IM. Effect of viscosity on particle size, deposition, and clearance of nasal delivery systems containing desmopressin. J Pharm Sci. 1988;77:405–8.
Cheng YS, Holmes TD, Gao J, Guilmette RA, Li S, Surakitbanharn Y, et al. Characterization of nasal spray pumps and deposition pattern in a replica of the human nasal airway. J Aerosol Med. 2001;14:267–80.
Foo MY, Cheng Y, Su W, Donovan MD. The influence of spray properties on intranasal deposition. J Aerosol Med. 2007;20(4):495–508.
Kimbell JS, Segal RA, Asgharian B, Wong BA, Schroeter JD, Southhall JP, et al. Characterization of deposition from nasal spray devices using a computational fluid dynamics model of the human nasal passages. J Aerosol Med. 2007;20:59–74.
Kundoor V, Dalby RN. Assessment of nasal spray deposition in a silicone human nose model using a color based method. Pharm Res. 2010;27(1):30–6.
Poochikian G, Shah V. Pharmaceutical quality assessment system (PQAS): science and risk managed approaches for inhalation drug products. In: Dalby RN, Byron PR, Peart J, Suman JD, editors. Respiratory Drug Delivery 2006 (Book 1, ISBN 1-930114-95-8). Davis Healthcare, River Grove: Illinois; 2006;151–8.
Pharmaceutical cGMPS for the 21st century—a risk-based approach. Rockville: US Food and Drug Administration; 2004.
Doughty DV, Vibbert C, Bollinger ME, Kewalramani A, Dalby RN. Automated Actuation of Nasal Spray Products: Determination and Comparison of Adult and Pediatric Settings. Drug Dev Ind Pharm. 2010;37(3):359–366.
Benninger MS, Hadley JA, Osguthorpe JD, Marple BF, Leopold DA, Derebery MJ, et al. Techniques of intranasal steroid use. Otolaryngol Head Neck Surg. 2004;130:5–24.
Guo Y, Laube B, Dalby R. The effect of formulation variables and breathing patterns on the site of nasal deposition in an anatomically correct model. Pharm Res. 2005;22(11):1871–8.
Pennington J, Pandey P, Tat H, Willson J, Donovan B. Spray pattern and droplet size analyses for high-shear viscosity determination of aqueous suspension corticosteroid nasal sprays. Drug Dev Ind Pharm. 2008;34:923–9.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kundoor, V., Dalby, R.N. Effect of Formulation- and Administration-Related Variables on Deposition Pattern of Nasal Spray Pumps Evaluated Using a Nasal Cast. Pharm Res 28, 1895–1904 (2011). https://doi.org/10.1007/s11095-011-0417-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-011-0417-6